FDA Centennial, 1906-2006

'The Past, Present, and Future of Regulating Food, Drugs, Medical Devices, and Nutritional Supplements'

The Food and Drug Administration regulates consumer products that make up one-quarter of the U.S. economy. From its origins in the USDA Department of Chemistry, the FDA has grown to nearly 10,000 employees and has a $1.8 billion annual budget. Its role in overseeing our nation's food supply, cosmetics, human and veterinary drugs, and medical devices is a frequent topic of policy debate.

About the Conference

This joint conference of the Food and Drug Administration and the Center for Contemporary History and Policy at the Chemical Heritage Foundation will examine the past 100 years of the FDA and facilitate discussion of current and near-term issues in risk and regulation. The conference will promote dialogue among regulators and constituent communities, including industry and public interest groups. Outcomes will include educating participants about issues in regulation and identifying models for the future.

Each panel will feature two 25-minute presentations, one by an FDA representative and one by an industry representative. Speakers will address how to regulate during a period of rapid change in science and technology, the relationship of regulation to competitiveness in a globalizing economy, and the role of business and government in light of changes in how consumers obtain and use health information.

Welcome and Introductions
Susan Setterberg, FDA Regional Director
Arthur Daemmrich, Director, Center for Contemporary History and Policy,
Suzanne White Junod, FDA Historian

Opening Plenary: Turning Points in FDA History
Peter Barton Hutt, Senior Counsel, Covington and Burling

Panel 1: Drug Regulation
Steven Galson, Director, FDA Center for Drug Evaluation and Research
Ronald Krall, Senior Vice President, Worldwide Development,

Panel 2: Medical Device Regulation
Daniel Schultz, Director, FDA Center for Devices and Radiological Health
Robert O'Holla, Vice President of Regulatory Affairs for Medical Devices
Diagnostic Products, Johnson & Johnson

Discussion: Drug and Medical Device Regulation
Moderator: Peter Doukas, Dean, Temple School of Pharmacy

Boxed lunch selections

Panel 3: Food Regulation
Robert Brackett, Director, FDA Center for Food Safety and Applied
F. Kerr Dow, Vice President of Global Innovation and Quality and Chief
Technical Officer, H.J. Heinz Company

Panel 4: Nutritional Supplements Regulation
Barbara Schneeman, Director, Office of Nutritional Products, Labeling,
and Dietary Supplements, FDA Center for Food Safety and Applied
Steven Mister, President and CEO, Council for Responsible Nutrition

Discussion: Food and Nutritional Supplements Regulation
Moderator: Ruth Schwartz Cowan, Chair, Department of History and
Sociology of Science, University of Pennsylvania

Closing Plenary: Risk, Regulation, and Enforcement
Andrew C. von Eschenbach, Acting FDA Commissioner


Please visit our new Web site: www.chemheritage.org

About Your Host

CHF's Center for Contemporary History and Policy (CCHP) carries out projects at the interface of science, regulation, and governance in order to provide knowledge and advice to stakeholders from industry, academia, government, and citizen groups.

Last reviewed: By John M. Grohol, Psy.D. on 30 Apr 2016
    Published on PsychCentral.com. All rights reserved.